Adaptive radiotherapy to decrease xerostomia in oropharynx carcinoma: cumulative dose model and predictors of toxicity

assignment_turned_inproject02 Jan 2012(Started)-02 Jan 2016(Ended)Closed

Funder: Institut National du CancerProject code: INCa-4924 Call for proposal: VADS11

Funded under: VADS

Adaptive radiotherapy to decrease xerostomia in oropharynx carcinoma: cumulative dose model and predictors of toxicity

- Summary
- DMPs

Partners

Hôpital Bretonneau , Centre Hospitalier Universitaire de Poitiers , INSERM U650 , Centre Eugène Marquis , Centre Antoine Lacassagne , Centre François Baclesse , Centre Oscar Lambret

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::ac04fab8ffb523eb807dd67975bd23c7&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Adaptive radiotherapy to decrease xerostomia in oropharynx carcinoma: cumulative dose model and predictors of toxicity

Adaptive radiotherapy to decrease xerostomia in oropharynx carcinoma: cumulative dose model and predictors of toxicity

Loading